FDA is alerting physicians and patients to the availability of corrective software, or updated “firmware,” to address cybersecurity risks for implantable cardiac pacemakers. “Cybersecurity risks in networked medical devices are constantly evolving, which means medical device manufacturers and hospitals must be vigilant in the face of changing threats in order to protect patient safety,” said William Maisel, acting director of the Office of Device Evaluation in an FDA statement issued Monday. “On August 23, 2017, the FDA approved a firmware...